A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Unfortunately, in up to 30–40% of patients that chronically consume opioids, opioid-induced hyperalgesia occurs. [59] This condition refers to a generalized and increasing pain sensitivity that ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Chronic pain is common in long-term hemodialysis patients A non-pharmacological treatment with cognitive and behavioral methods helps in pain management The program does not involve medications ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

With the evolving technologies and methodologies of pain management treatment, experts are encouraging folks suffering from chronic pain to get with a pain ...

Aims: The use of medication in pain management currently involves empirical ... the clinical effectiveness of genotyping chronic pain patients on analgesic therapy. It was hypothesized that ...

Black individuals in the U.S. with serious illnesses receive disproportionately poor pain management and health care ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...